Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Cabaletta Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get CABA alerts

About Steven Nichtberger

Steven Nichtberger is recorded as Board Member at Cabaletta Bio, Inc. (CABA) since January 1, 2017 and CEO at Cabaletta Bio, Inc. (CABA). The newest filing on record that lists Steven Nichtberger as CEO and Board Member at Cabaletta Bio, Inc. (CABA) is dated April 28, 2026. Steven Nichtberger has spoken on 2 investor events across 1 company, most recently for Cabaletta Bio, Inc. on September 16, 2026. Cabaletta Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cabaletta Bio, Inc. includes Anup Marda (CFO), Michael Gerard (General Counsel), Scott Brun (Board Member) and 3 others.

Steven Nichtberger on recent calls

“So, listen, patients who have autoimmune disease simply want to get rid of their symptoms, get rid of their medicines, and just be normal people. They don't want to have the patient label.”
CEO, H.C. Wainwright 28th Annual Global Investment Conference ·
“So, listen, patients who have autoimmune disease simply want to get rid of their symptoms, get rid of their medicines, and just be normal people. They don't want to have the patient label.”
CEO, Morgan Stanley 24th Annual Global Healthcare Conference ·

Affiliation history

Company network

Leadership on record at Cabaletta Bio, Inc.

Recent activity